NLM Digital Collections

Search

Start Over Subjects Prospective Payment System ✖Remove constraint Subjects: Prospective Payment System Publication Year 2000 to 2023 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2023">2023</span>

4. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2017
Subject(s):
Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Prospective Payment System
Abatacept -- economics
Certolizumab Pegol -- economics
Cost Savings
Injections -- economics
Self Care -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
Healthcare common procedure coding system

5. Federally qualified health centers and state health policy: a primer for California

Publication:
Oakland, Calif. : California HealthCare Foundation, [2009]
Subject(s):
Community Health Centers -- organization & administration
Health Policy
Adult
Child
Child Health Services
Chronic Disease -- economics
Education, Medical, Graduate -- economics
Eligibility Determination
Federal Government
Fee-for-Service Plans
Financing, Government
Health Manpower
Health Services Accessibility
Licensure
Managed Care Programs
Medicaid
Medically Underserved Area
Mental Health Services
Pilot Projects
Primary Health Care
Prospective Payment System
Rural Health Services -- economics
State Government
Transients and Migrants
Humans
California

6. Indication-specific pricing of pharmaceuticals in the United States health care system: a report from the 2015 ICER Membership Policy Summit

Author(s):
Pearson, Steven D., author
Dreitlein, Bill, author
Henshall, Chris, author
Publication:
Boston, MA : Institute for Clinical and Economic Review, March 2016
Subject(s):
Drug Costs
Economics, Pharmaceutical
Insurance, Pharmaceutical Services -- economics
Prospective Payment System
Reimbursement Mechanisms -- economics
Cost Savings
Cost Sharing
Formularies
Medicaid -- economics
Medicare -- economics
Off-Label Use -- economics
Pilot Projects
Value-Based Purchasing
Humans
United States

9. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):
Clinical Laboratory Techniques -- economics
Insurance, Health, Reimbursement
Medicare Part B -- economics
Prospective Payment System
Rate Setting and Review
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

10. Medicare payments for clinical diagnostic laboratory tests in 2017: year 4 of baseline data

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2018
Subject(s):
Clinical Laboratory Techniques -- economics
Insurance, Health, Reimbursement
Medicare Part B -- economics
Prospective Payment System
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)